Multi-Center PAMPA Study
Public ClinicalTrials.gov record NCT05004727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Preventing Arthritis in a Multi-Center Psoriasis At-Risk Cohort
Study identification
- NCT ID
- NCT05004727
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2022
- Primary completion
- Dec 30, 2026
- Completion
- Nov 1, 2028
- Last update posted
- Mar 29, 2026
2022 – 2028
United States locations
- U.S. sites
- 3
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Recruiting |
| NYU Langone Health | New York | New York | 10016 | Recruiting |
| University of Rochester Medical Center (URMC) | Rochester | New York | 14623 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
Recently updated Psoriasis trials
Other public records listing Psoriasis. Sorted by last update posted; newest first. Not a recommendation.
- NCT02707341: The CorEvitas Psoriasis (PSO) Registry Recruiting
- NCT07654751: A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically Not yet recruiting
- NCT03816345: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO Recruiting
- NCT07489885: A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis Recruiting
- NCT06574178: Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet Recruiting
- NCT07648602: PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05004727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2026 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05004727 live on ClinicalTrials.gov.